Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 60.20
+0.65 (1.09%)
May 28, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 99.30 billion as of May 28, 2025. Its market cap has increased by 45.83% in one year.
Market Cap
99.30B
Enterprise Value
93.92B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
60.20
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 99.30B, an increase of 435.64%. That is a compound annual growth rate of 29.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 223.86B |
| Hansoh Pharmaceutical Group Company | 152.21B |
| JD Health International | 130.96B |
| WuXi Biologics | 93.90B |
| CSPC Pharmaceutical Group | 74.52B |
| Akeso | 73.06B |
| Sino Biopharmaceutical | 72.65B |
| Alibaba Health Information Technology | 70.76B |